SAN ANTONIO — Industry giants like Microsoft and Google, as well as much smaller start ups, are in a race to create new kinds of artificial intelligent systems that could be the next big thing in ...

Scientific software specialist Dotmatics acquired M-Star, a computational fluid dynamics (CFD) software company headquartered outside of Baltimore. The deal, which marks the thirteenth acquisition by ...

Thomas Swalla, CEO of Dotmatics, takes a look at how the power of data science can help aid in R&D innovations. At its core, science is about discovering hidden truths. Some of those truths are so ...

Artificial intelligence is making it quicker to get drug candidates to the clinic, but it isn’t addressing the fundamental need to marry the right candidate and the right target to the right disease.

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Even as enterprises across sectors explore how to integrate generative AI ...

Ten years and $2.5 billion — that’s what it takes, on average, to bring a new drug to market in the United States. Artificial intelligence promises to supercharge this process, drastically reducing ...